Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma

被引:110
作者
de Vries, M.
Vonkeman, W. G.
van Ginkel, R. J.
Hoekstra, H. J.
机构
[1] Univ Med Ctr Groningen, Dept Surg Oncol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, NL-9700 RB Groningen, Netherlands
来源
EJSO | 2006年 / 32卷 / 07期
关键词
melanoma; sentinel lymph node; groin dissection; wound infection; lymphedema;
D O I
10.1016/j.ejso.2006.05.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Aim of the study was to assess the short-term and long-term morbidity after inguinal sentinel lymph node biopsy (SLNB) with or without completion groin dissection (GD) in patients with cutaneous melanoma. Methods: Between 1995 and 2003, 127 inguinal SLNBs were performed for cutaneous melanoma. Sixty-six patients, median age 50 (18-77) years, met the inclusion criteria and were studied. Short-term complications were analysed retrospectively, while long-term complications were evaluated using volume measurement and range of motion measurement of the lower extremities. Results: Fifty-two patients underwent SLNB alone (SLNB group) and 14 patients underwent completion groin dissection after tumour-positive SLNB (SLNB/GD group). Morbidity after SLNB alone: wound infections (n = 1), scroma (n = 1), postoperative bleeding (n = 1), erysipelas (n = 1), and slight lymphedema 6% (n = 3). Morbidity after SLNB/GD: wound infections (n = 4), seroma (17 = 1), wound necrosis (n = 1), postoperative bleeding (n = 1), and slight lymphedema 64% (n = 9). There were differences between the two groups in the total number of short-term complications (p < 0.001), volume difference (p < 0.001), flexion (p = 0.009), and abduction (p = 0.011) limitation of the hip joint. Conclusion: Inguinal SLNB is accompanied with a low complication rate. However, SLNB followed by groin dissection is associated with an increased risk of wound infection and slight lymphedema. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:785 / 789
页数:5
相关论文
共 19 条
[1]  
BAAS PC, 1992, ARCH SURG-CHICAGO, V127, P281
[2]   OPERATIVE MORBIDITY AND RISK FACTOR ASSESSMENT IN MELANOMA PATIENTS UNDERGOING INGUINAL LYMPH-NODE DISSECTION [J].
BEITSCH, P ;
BALCH, C .
AMERICAN JOURNAL OF SURGERY, 1992, 164 (05) :462-466
[3]   Morbidity after axillary sentinel lymph node biopsy in patients with cutaneous melanoma [J].
de Vries, M ;
Vonkeman, WG ;
van Ginkel, RJ ;
Hoekstra, HJ .
EJSO, 2005, 31 (07) :778-783
[4]   Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma [J].
Doting, MHE ;
Hoekstra, HJ ;
Plukker, JTM ;
Piers, DA ;
Jager, PL ;
Tiebosch, ATMG ;
Vermey, A ;
Koops, HS .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (06) :673-678
[5]   Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients [J].
Gershenwald, JE ;
Thompson, W ;
Mansfield, PF ;
Lee, JE ;
Colome, MI ;
Tseng, CH ;
Lee, JJ ;
Balch, CM ;
Reintgen, DS ;
Ross, MI .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) :976-983
[6]   GROIN DISSECTION IN MALIGNANT-MELANOMA [J].
KARAKOUSIS, CP ;
DRISCOLL, DL .
BRITISH JOURNAL OF SURGERY, 1994, 81 (12) :1771-1774
[7]   RISK OF LYMPHEDEMA FOLLOWING THE TREATMENT OF BREAST-CANCER [J].
KISSIN, MW ;
DELLAROVERE, GQ ;
EASTON, D ;
WESTBURY, G .
BRITISH JOURNAL OF SURGERY, 1986, 73 (07) :580-584
[8]  
Koops HS, 1999, RADIOTHER ONCOL, V51, P1
[9]  
KRAG DN, 1995, ARCH SURG-CHICAGO, V130, P654
[10]   Sentinel node biopsy for early-stage melanoma - Accuracy and morbidity in MSLT-I, an international multicenter trial [J].
Morton, DL ;
Cochran, AJ ;
Thompson, JF ;
Elashoff, R ;
Essner, R ;
Glass, EC ;
Mozzillo, N ;
Nieweg, OE ;
Roses, DF ;
Hoekstra, HJ ;
Karakousis, CP ;
Reintgen, DS ;
Coventry, BJ ;
Wang, HJ .
ANNALS OF SURGERY, 2005, 242 (03) :302-313